| Target Validation Information | |||||
|---|---|---|---|---|---|
| Target ID | T02546 | ||||
| Target Name | Sodium channel protein type 4 subunit alpha | ||||
| Target Type | Clinical Trial |
||||
| Drug Potency against Target | 3-[4-(4-Fluoro-phenoxy)-phenyl]-1H-pyrazole | Drug Info | Ki = 200 nM | [526983] | |
| 3-(4-Phenoxy-phenyl)-1H-pyrazole | Drug Info | Ki = 240 nM | [526983] | ||
| V-102862 | Drug Info | Ki = 180 nM | [526983] | ||
| References | |||||
| Ref 526983 | J Med Chem. 2004 Mar 11;47(6):1547-52.3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers. | ||||
| Ref 526983 | J Med Chem. 2004 Mar 11;47(6):1547-52.3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers. | ||||
| Ref 526983 | J Med Chem. 2004 Mar 11;47(6):1547-52.3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.